Related Experiment Videos
In vitro bacterial adherence to ventriculoperitoneal shunts
G Livni1, Y Yuhas, S Ashkenazi
1Department of Pediatrics A, Unit of Pediatric Infectious Diseases, Schneider Children's Medical Center of Israel, Tel Aviv, Israel. lgilat@clalit.org.il
Pediatric Neurosurgery
|August 5, 2004
Summary
Bacterial adherence to ventriculoperitoneal (VP) shunts is crucial for infection. Staphylococcus epidermidis and S. aureus showed the highest adherence, influenced by factors like material and bacterial properties.
Area of Science:
- Microbiology
- Biomaterials Science
- Infectious Diseases
Background:
- Bacterial adherence to medical devices initiates infections.
- Understanding bacterial adherence to ventriculoperitoneal (VP) shunts is critical but not fully understood.
- VP shunts are susceptible to bacterial colonization, leading to serious complications.
Purpose of the Study:
- To quantitatively assess in vitro bacterial adherence to VP shunts.
- To identify specific bacteria responsible for VP shunt infections.
- To determine factors influencing bacterial adherence to VP shunts.
Main Methods:
- Quantitative adherence measurement (bacteria/cm²).
- Electron microscopy for visualization.
- Assessment of slime production and hydrophobicity.
- Testing of clinical isolates: Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli.
Main Results:
- All tested bacteria adhered to VP shunts, with significant differences observed.
- Staphylococcus epidermidis (67.0 x 10³ bacteria/cm²) and Staphylococcus aureus (15.2 x 10³ bacteria/cm²) exhibited the highest adherence.
- Adherence was influenced by incubation time, temperature, bacterial concentration, device material (silicone vs. Teflon), slime production, and hydrophobicity.
Conclusions:
- Bacterial adherence to VP shunts varies significantly among common pathogens.
- Factors such as bacterial characteristics and material properties play a key role in adherence.
- Findings provide insights for developing strategies to prevent VP shunt infections.